Stadler, Eva http://orcid.org/0000-0002-5129-8180
Burgess, Martin T.
Schlub, Timothy E. http://orcid.org/0000-0001-7746-9649
Khan, Shanchita R. http://orcid.org/0000-0003-0772-6122
Chai, Khai Li
McQuilten, Zoe K.
Wood, Erica M. http://orcid.org/0000-0001-7527-2340
Polizzotto, Mark N.
Kent, Stephen J. http://orcid.org/0000-0002-8539-4891
Cromer, Deborah
Davenport, Miles P. http://orcid.org/0000-0002-4751-1831
Khoury, David S. http://orcid.org/0000-0002-2663-1551
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
Article History
Received: 23 January 2023
Accepted: 18 July 2023
First Online: 28 July 2023
Competing interests
: M.N.P. declares receiving provision of drugs for clinical trials from CSL Behring, Takeda, Grifols, Emergent Biosciences, and Gilead. Z.K.M. and E.M.W. declare research funding from CSL Behring to Monash University for work outside this project. The authors declare no other competing interests.
: This work was approved under the UNSW Sydney Human Research Ethics Committee (approval HC200242).